9035 POSTER A National, Multi Center, Randomized, Open-label, Phase II Study of Erlotinib Versus Gemcitabine (GEM) Plus Cisplatin as Neoadjuvant Treatment in Stage IIIA-N2 Non-small-cell Lung Cancer (NSCLC) Patients (pts) With Activating EGFR Mutations (C-TONG 1103)

✍ Scribed by Zhonq, W.; Wu, Y.; Wang, C.; Mao, W.; Xu, L.; Cheng, Y.; Yang, X.; Chen, K.

• Book ID: 123066095
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 59 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72347-4